MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Fresenius Medical Care AG & Co. KGaA Company Profile (ETR:FME)

Consensus Ratings for Fresenius Medical Care AG & Co. KGaA (ETR:FME) (?)
Ratings Breakdown: 2 Sell Rating(s), 7 Hold Rating(s), 14 Buy Rating(s)
Consensus Rating:Buy (Score: 2.52)
Consensus Price Target: €86.30

Analysts' Ratings History for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
Show:
DateFirmActionRatingPrice TargetActions
6/30/2016Oddo SecuritiesSet Price TargetBuy€90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/28/2016Goldman SachsSet Price TargetBuy€94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/27/2016Sanford C. BernsteinSet Price TargetBuy€92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016Baader BankSet Price TargetBuy€90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/31/2016Berenberg BankSet Price TargetBuy€91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/24/2016Bank of AmericaSet Price TargetBuy€94.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2016Nord/LBSet Price TargetBuy€93.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016BarclaysSet Price TargetSell€71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016BNP ParibasSet Price TargetNeutral€78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Credit SuisseSet Price TargetBuy€88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016Deutsche BankSet Price TargetNeutral€77.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Societe GeneraleSet Price TargetNeutral€79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Independent Research GmbHSet Price TargetBuy€95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Bankhaus LampeSet Price TargetBuy€80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016JPMorgan Chase & Co.Set Price TargetBuy€105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2016Commerzbank AGSet Price TargetNeutral€80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2016HSBCSet Price TargetNeutral€83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Jefferies GroupSet Price TargetSell€64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016NomuraSet Price TargetBuy€99.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2016Warburg ResearchSet Price TargetNeutral€85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2016Kepler Capital MarketsSet Price TargetBuy€87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2016Morgan StanleySet Price TargetBuy€91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2015S&P Equity ResearchSet Price TargetNeutral€79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/1/2014 forward)
Earnings History for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Fresenius Medical Care AG & Co. KGaA (ETR:FME)
DateHeadline
07/01/16 05:28 AMAURELIUS SE & Co KGaA, DE000A0JK2A8
06/29/16 05:13 AMFresenius (ETR:FRE) stock price target raised to EUR70 as announced today by Deutsche Bank AG
06/21/16 07:30 AMFresenius Medical Care North America Significantly Reduces Mortality and Hospitalization for Dialysis Patients - [Business Wire] - Fresenius Medical Care North America , the nation’s leading fully integrated provider of kidney disease-related products and services, announced today that it has dramatically improved patient outcomes over the last decade.
06/06/16 09:29 PMAsia and North Africa Hemodialysis & Peritoneal Dialysis Market Worth 35.9 Billion USD by 2020
06/03/16 10:12 PMDGAP-DD: Fresenius Medical Care AG & Co. KGaA english
06/03/16 09:25 AMFresenius Medical Care establishes regenerative medicine subsidiary, to continue successful work with University of Turin - [at noodls] - Press Release Fresenius Medical Care, the world's largest provider of dialysis products and services, has established a subsidiary focusing on regenerative medicine. Unicyte AG will pursue research into ...
05/31/16 09:51 PMFresenius Medical Care KGaA : launches 6008 CAREsystem, a new hemodialysis therapy system enabling better care for chronic patients - These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward ...
05/31/16 07:22 AMFresenius Medical Care launches 6008 CAREsystem, a new hemodialysis therapy system enabling better care for chronic patients - [at noodls] - Press Release Fresenius Medical Care, the world's largest provider of dialysis products and services, has launched the 6008 CAREsystem for the treatment of patients with end-stage renal disease (ESRD). ...
05/25/16 10:43 AMFresenius Medical Care KGaA : expects continued, strong growth – Annual General Meeting approves 19th consecutive dividend increase - Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS ... These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA's reports filed with the U.S. Securities ...
05/25/16 09:06 AMFresenius Medical Care expects continued, strong growth – Annual General Meeting approves 19th consecutive dividend increase - [at noodls] - Press Release Fresenius Medical Care, the world's leading provider of dialysis products and services, expects significant sales and earnings growth in 2016. At the Annual General Meeting in Frankfurt today, ...
05/11/16 07:18 AMFresenius Medical (FMS) Q1 Earnings & Sales Lag Estimates -
05/09/16 08:54 AMOPKO Inks Win-Win Deal With Swiss Pharma -
05/09/16 07:55 AMBillionaire's company inks $282 million deal with Swiss firm -
05/03/16 12:17 AMFresenius net profit up 24 percent on generic infusion drugs -
05/03/16 12:10 AMFresenius Medical Care reports strong start to the year 2016 - [at noodls] - Investor NewsFinancialsFinancialsPress Release Group revenue increased +6%, strong net income growth of +9% North America: revenue +10%, significant increase of operating income (EBIT) +28% Segments outside ...
04/25/16 08:44 AMFresenius Medical Care North America to Present Range of Clinical Findings Focused on Improving Renal Patient Care and Health Outcomes at the National Kidney Foundation 2016 Spring Clinical Meetings - [Business Wire] - Fresenius Medical Care North America , the continent’s leading provider of kidney care products and services, announced today that the National Kidney Foundation accepted a significant number of abstracts authored by FMCNA clinicians and caregivers for presentation at the 2016 Spring Clinical Meetings and publication in the journals affiliated with NKF.
04/14/16 10:08 AMRecent Analysts' Ratings Updates for Fresenius Medical Care AG & Co. (Pref) (FME) - Washington News Wire - Recent Analysts' Ratings Updates for Fresenius Medical Care AG & Co. (Pref) (FME)Washington News WireFresenius Medical Care AG & Co. (Pref) logo Fresenius Medical Care AG & Co. (Pref) (ETR: FME) has recently received a number of price target changes and ratings updates: Fresenius Medical Care AG & Co. (ETR:FME) opened at 78.786 on Thursday.and more »
04/13/16 10:04 AMAre Analysts Bearish Henkel AG & Co KGaA (ETR:HEN) After Last Week? - equities analysts expect that Fresenius Medical Care AG & Co. will post $2.04 earnings per share for the current fiscal year. The fund owned 274,935 shares of the company's stock after buying an additional 10,479 shares during the period. (Pref ...
04/12/16 09:44 AMInvestment Analysts' Price Target Changes for April, 11th (ARX, BCE, DSG, FE, FME, HAL, HTZ, LUN, MDXG, MTE) - Washington News Wire - Investment Analysts' Price Target Changes for April, 11th (ARX, BCE, DSG, FE, FME, HAL, HTZ, LUN, MDXG, MTE)Washington News WireFresenius Medical Care AG & Co. (Pref) (ETR:FME) was given a €95.00 ($107.95) price target by analysts at Independent Resear…. The firm currently has a a buy rating on the stock. Halliburton Company (NYSE:HAL) had its target price raised by KLR Group ...and more »
04/12/16 09:44 AMFresenius Medical Care AG & Co. (Pref) (FME) Given a €64.00 Price Target at Jefferies Group - Washington News Wire - The Vista VoiceFresenius Medical Care AG & Co. (Pref) (FME) Given a €64.00 Price Target at Jefferies GroupWashington News WireFresenius Medical Care AG & Co. (Pref) logo Fresenius Medical Care AG & Co. (Pref) (ETR:FME) received a €64.00 ($72.73) price target from investment analysts at Jefferies Group in a research report issued on Tuesday, Market Beat Ratings reports.Fresenius Medical Care AG & Co. (Pref) (FME) Given a €105.00 Price Target by JPMorgan Chase & Co. AnalystsThe Vista VoiceFresenius Medical Care AG & Co. (Pref) (FME) Given a €95.00 Price Target at Independent Resear...Web Breaking Newsall 26 news articles »
04/11/16 10:27 AMResearch Analysts' Price Target Changes for April, 11th (AKG, AR, BEI, BTO, CG, CNL, CP, DBK, DGC, DNA) - Washington News Wire - Research Analysts' Price Target Changes for April, 11th (AKG, AR, BEI, BTO, CG, CNL, CP, DBK, DGC, DNA)Washington News WireFresenius Medical Care AG & Co. (Pref) (ETR:FME) was given a €92.00 ($104.55) target price by analysts at Sanford C. Bernstein. The firm currently has a a buy rating on the stock. Franco-Nevada (TSE:FNV) had its target price increased by RBC Capital ...and more »
03/21/16 08:00 AMAmerican Association of Kidney Patients Awards Fresenius Medical Care Caregivers with its Highest Honor for Health Care Professionals - [Business Wire] - Fresenius Medical Care North America , the continent’s leading provider of kidney care products and services, and the American Association of Kidney Patients , announced today that AAKP has presented its 2016 Medal of Excellence Award to four FMCNA caregivers at the Renal Physicians Association Annual Meeting in Chandler, Arizona, the highest number of awards for a single organization.
03/18/16 09:20 AMCapital Square 1031 Acquires Medical Office Building in Winchester, Va. - March 17, 2016 (GLOBE NEWSWIRE) -- Capital Square 1031 announced today that the company has acquired a medical office building, 100 percent leased to Bio-Medical Applications of Virginia, doing business as Fresenius Medical Care Holdings Inc., in ...
03/10/16 08:57 AMHow Many Fresenius Medical Care AG & Co. (Pref) (ETR:FME)'s Analysts Are Bullish? - RiversideGazette.com - How Many Fresenius Medical Care AG & Co. (Pref) (ETR:FME)'s Analysts Are Bullish?RiversideGazette.comThis means 53% are positive. Fresenius Medical Care was the topic in 44 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a list of Fresenius Medical Care AG & Co. (Pref) (ETR:FME) latest ratings and price target changes.and more »
02/25/16 11:20 AMFresenius Medical Misses on Q4 Earnings and Revenues -
02/24/16 04:29 AMFMC aims for 110,000 U.S. patients to be on Mircera in Q1 -
02/24/16 02:49 AMFresenius sees further growth after 'remarkable' performance in 2015 -
02/19/16 08:31 AMFresenius Medical Care reaches agreement to resolve GranuFlo/NaturaLyte lawsuits - (Pref) (ETR:FME) has declined 1.08% since June 2, 2015 and is downtrending. JPMorgan Chase & Co. set a €68.70 ($76.33) target price on shares of Fresenius Medical Care AG & Co. "This new partnership to provide extensive and far-reaching kidney dialysis ...
02/10/16 11:18 AMNxStage Medical Grows but Expects No Profit for 2016 -
02/09/16 06:30 AMInterface Biologics Announces the Extension of its Licensing Agreement with Fresenius Medical Care - [Marketwired] - Interface Biologics Inc. , a privately held commercial stage developer of transformative biomedical-polymer products, is pleased to announce that Fresenius Medical Care , the worlds' largest integrated ...
01/18/16 04:29 PMDGAP-PVR: Fresenius Medical Care AG & Co. KGaA: -2- - 14.01. Fresenius Medical Care AG : Shortsignal nach Turtle Trading Strategie (73.48 Euro, Short) 14.01. Fresenius Medical Care AG : Shortsignal nach Turtle Trading Strategie (74.23 Euro, Short) 14.01. Fresenius Medical Care AG : Fallen unter mittelfristige ...
12/29/15 09:07 AMAmgen’s Nephrology Drugs Expect Falling Revenue in 4Q15 -
11/16/15 11:04 AMAmgen’s Bone and Nephrology Drugs Register Solid Growth in 3Q15 -
11/06/15 04:30 PMNxStage Medical Makes More Progress Toward Profitability -
11/04/15 07:00 AMFresenius Medical Care North America 2015 Health Indicator Survey Finds Americans and Physicians Are Not Confident in the Ability of the U.S. Health Care System to Meet the Needs of Chronically Ill Patients - [Business Wire] - The U.S. health care system does not optimally meet the unique needs of people with chronic conditions, according to research findings released today by Fresenius Medical Care North America , a division of Fresenius Medical Care .
11/03/15 01:00 AMDebiotech and Fresenius Medical Care Announce Exclusive Partnership for New Home Dialysis Product Development - [PR Newswire] - The new product platform will offer dialysis machines that are lightweight and compact, making it more practical to dialyze at home. The smaller size of Fresenius Medical Care's new generation of PD machines will provide flexibility for dialysis patients when they travel, their intuitive design will promote ease of use, and their accompanying teaching methods are intended to make it easy for patients who are new to PD to use the machines. Experts from both companies are working together to plan for multiple generations of innovations, offering more patients the option to dialyze at home than ever before.
10/30/15 10:46 AMFresenius (FMS) Q3 Earnings, Revenues Miss; Outlook Intact -
10/29/15 01:08 AMFresenius Medical Care reports third quarter 2015 results and confirms guidance for full year 2015 - [at noodls] - Investor News Press Release 2015 outlook confirmed Strong organic growth and very positive earnings development in North America Strong growth dynamic in Care Coordination activities International performance ...
10/02/15 08:08 AMHow Does Cantel Medical Compare to Its Peers? -
09/21/15 05:25 AMFresenius Medical Care provides historical segment data - [at noodls] - Investor News Bad Homburg, Germany - Fresenius Medical Care AG & Co. KGaA ('the company' or 'Fresenius Medical Care'), the world's largest provider of dialysis products and services, has aligned the disclosure ...
07/31/15 09:48 AMFresenius Medical Q2 Earnings Miss, Revenues Top Estimates - Analyst Blog -
07/29/15 04:07 PMFresenius Medical Care reports second quarter 2015 results and confirms guidance for full year 2015 - [at noodls] - Investor NewsPress Release Second quarter performance on track to achieve full year guidance for 2015 Strong year to date revenue and earnings growth International performance mainly masked by currencies ...
07/02/15 09:05 AMFresenius Medical Care’s Patient Engagement May Have Saved Lives During Superstorm Sandy - [Business Wire] - Fresenius Medical Care North America , a division of Fresenius Medical Care and North America’s largest provider of kidney care, hospitalist services and renal products, today hailed a new study by the Department of Health and Human Services this week showing that dialysis patients who received treatments immediately before Super Storm Sandy experienced a much better survival rate and less frequent ...
05/28/15 06:30 AMFresenius Medical Care Joins Health Care Transformation Task Force - [Business Wire] - The newly formed Health Care Transformation Task Force, a partnership of leading health care payers, providers, purchasers and patient organizations, announced today that Fresenius Medical Care North America has joined its membership, and Ron Kuerbitz, CEO of Fresenius Medical Care North America, has been named to serve on the group’s board.
05/05/15 01:26 PMFresenius Medical Earnings Lag, Revenues Beat Expectations - Analyst Blog -
04/29/15 03:49 PMFMC confirms outlook as quarterly profit in line -
About Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care AG & Co. KGaA logoFresenius Medical Care AG & Co. KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America. The Company develops and manufactures a range of dialysis machines, systems and disposable products. The Company's dialysis business provides dialysis treatment at its own dialysis clinics and supplies the clinics with a range of products. In addition, it sells dialysis products to other dialysis service providers. The Company's Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, and health plan services and urgent care services.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: ETR
  • Symbol: FME
  • CUSIP:
Key Metrics:
  • Previous Close: $77.91
  • 50 Day Moving Average: $75.261
  • 200 Day Moving Average: $76.443
  • P/E Ratio: N/A
  • P/E Growth: 1.700
  • Market Cap: $N/A
  • Current Quarter EPS Consensus Estimate: $4.060 EPS
Additional Links:

            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha